AAP Grand Rounds Subscribe to Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
 Vol. 14 No. 6, December 2005
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varma, S. K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Varma, S. K.
Related Collections
Right arrow Clinical Pharmacology and Therapeutics
Right arrow Endocrinology

AAP Grand Rounds 14:68 (2005)
© 2005 American Academy of Pediatrics

ENDOCRINOLOGY

Insulin Pump in Young Children with Diabetes

Source: Fox LA, Buckloh LM, Smith SD, et al. A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care. 2005;28:1277–1281.[Abstract/Free Full Text]

The first 20% of the full text of this article appears below.

In infants and toddlers with type 1 diabetes, achieving tight control of blood glucose is challenging. Investigators from Nemours Children’s Clinic in Jacksonville, Fla., randomized children aged 1 to 6 years with type 1 diabetes into 2 groups to compare glycemic control and impact on family life between children receiving traditional insulin injections and those receiving insulin by pump. Children in the injection group received 2 or 3 daily shots of long-acting insulin (NPH) and rapid-acting insulin analog. The pump group received continuous subcutaneous insulin infusion therapy. Both groups were monitored for mean blood glucose, hypoglycemia frequency, diabetes-related quality of life (QOL), parental adjustment, . . . [Full Text of this Article]

Surendra K. Varma, MD, FAAP
Endocrinology, Texas Tech University Health Sciences Center, Lubbock, TX

 





HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Academy of Pediatrics.